4//SEC Filing
VOGELBAUM MARTIN 4
Accession 0001209191-21-038766
CIK 0001346830other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 7:35 PM ET
Size
10.3 KB
Accession
0001209191-21-038766
Insider Transaction Report
Form 4
VOGELBAUM MARTIN
Director
Transactions
- Award
Common Stock
2021-06-03+14,400→ 28,800 total - Sale
Common Stock
2021-06-07$13.05/sh−8,640$112,752→ 20,160 total - Award
Stock Option (Right to Buy)
2021-06-03+21,600→ 21,600 totalExercise: $13.06Exp: 2031-06-03→ Common Stock (21,600 underlying)
Footnotes (4)
- [F1]Represents the number of shares underlying restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of (i) June 3, 2022 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date.
- [F2]Represents the number of shares sold by the Reporting Person to satisfy the Reporting Person's tax obligations resulting from the settlement of vested RSUs on June 3, 2021. The sales were effected pursuant to a "sell-to-cover" arrangement adopted in accordance with Rule 10b5-1 on May 28, 2021.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.99 to $13.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F4]This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) June 3, 2022 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001237624
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 7:35 PM ET
- Size
- 10.3 KB